Latest news from Sylvester Comprehensive Cancer Center on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/astro-2024-tip-sheet-from-sylvester-comprehensive-cancer-center/?sc=rsin /articles/astro-2024-tip-sheet-from-sylvester-comprehensive-cancer-center/?sc=rsin Tue, 03 Sep 2024 19:05:13 EST Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami will be presented at ASTRO 2024 - the American Society for Radiation Oncology's annual meeting Sept. 29 - Oct. 2 in Washington D.C. Below are titles for oral presentations, posters and special sessions in which our researchers will be involved. Sylvester Comprehensive Cancer Center /articles/experts-on-the-front-lines-of-blood-cancer-see-hope-for-cures/?sc=rsin /articles/experts-on-the-front-lines-of-blood-cancer-see-hope-for-cures/?sc=rsin Tue, 03 Sep 2024 13:05:58 EST Expert sources and news tips from Sylvester Comprehensive Cancer Center for Blood Cancer Awareness Month in September. Sylvester Comprehensive Cancer Center /articles/study-some-lung-cancer-disparities-lessen-in-south-florida/?sc=rsin /articles/study-some-lung-cancer-disparities-lessen-in-south-florida/?sc=rsin Sun, 25 Aug 2024 23:05:04 EST When it comes to cancer disparities, community may count. A new study in the Journal of the National Cancer Institute showed that although Hispanic non-small cell lung cancer patients tend to be diagnosed at later stages than White patients, that disadvantage disappears in South Florida. Sylvester Comprehensive Cancer Center /articles/sylvester-cancer-tip-sheet-august-2024/?sc=rsin /articles/sylvester-cancer-tip-sheet-august-2024/?sc=rsin Thu, 22 Aug 2024 17:05:26 EST A mouthwash-like rinse to predict head and neck cancer recurrence, new research identifies biomarkers to predict which colon cancer patients benefit from adjuvant chemotherapy, the Dolphins Cancer Challenge and more are included in this month's tip sheet. Sylvester Comprehensive Cancer Center /articles/can-a-mouthwash-based-test-help-predict-head-and-neck-cancer-recurrence/?sc=rsin /articles/can-a-mouthwash-based-test-help-predict-head-and-neck-cancer-recurrence/?sc=rsin Thu, 15 Aug 2024 11:00:00 EST Mouthwash has long been marketed as an essential hygiene item to prevent bad breath. But what if a mouthwash-based test to detect biomarkers can help predict recurrence of head and neck cancer? Sylvester Comprehensive Cancer Center /articles/jama-oncology-review-the-latest-treatment-options-for-acute-myeloid-leukemia/?sc=rsin /articles/jama-oncology-review-the-latest-treatment-options-for-acute-myeloid-leukemia/?sc=rsin Fri, 09 Aug 2024 01:05:31 EST New drug combinations and targeted therapies may offer a brighter future for patients with acute myeloid leukemia - especially among older adults and others who may be more frail. A review in JAMA Oncology. Sylvester Comprehensive Cancer Center /articles/study-identifies-biomarker-that-could-predict-whether-colon-cancer-patients-benefit-from-chemotherapy/?sc=rsin /articles/study-identifies-biomarker-that-could-predict-whether-colon-cancer-patients-benefit-from-chemotherapy/?sc=rsin Fri, 26 Jul 2024 16:05:45 EST A new study identifies and validates a 10-gene biomarker that potentially predicts whether a stage II or III colon cancer patient will benefit from adjuvant chemotherapy. A secondary finding from the study suggests that the gene signature could potentially also predict whether immunotherapy would help some patients. Sylvester Comprehensive Cancer Center /articles/three-junior-faculty-members-join-sylvester-comprehensive-cancer-center-s-k12-faculty-scholars-at-annual-symposium/?sc=rsin /articles/three-junior-faculty-members-join-sylvester-comprehensive-cancer-center-s-k12-faculty-scholars-at-annual-symposium/?sc=rsin Thu, 25 Jul 2024 14:05:50 EST Three junior faculty members at Sylvester Comprehensive Cancer Center have been named K12 2024 Faculty Scholars. The program awards recipients with resources to pursue independent research careers in clinical and translational cancer research. Sylvester Comprehensive Cancer Center /articles/sylvester-science-contributes-to-guidelines-for-anal-cancer/?sc=rsin /articles/sylvester-science-contributes-to-guidelines-for-anal-cancer/?sc=rsin Wed, 24 Jul 2024 17:05:44 EST Federal health officials recently released new guidelines for anal cancer screening to protect people with HIV, an achievement made possible by a landmark study conducted at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and Jackson Memorial Hospital, and other research institutions. Sylvester Comprehensive Cancer Center /articles/cancer-survivors-and-doctors-show-their-olympic-mettle/?sc=rsin /articles/cancer-survivors-and-doctors-show-their-olympic-mettle/?sc=rsin Wed, 24 Jul 2024 15:05:23 EST Sylvester Comprehensive Cancer Center /articles/sunscreen-is-your-best-friend-this-summer/?sc=rsin /articles/sunscreen-is-your-best-friend-this-summer/?sc=rsin Fri, 28 Jun 2024 16:05:32 EST Soaking up rays by the beach or pool feels good, but it's harsh for your skin. The United States lacks advanced formula sunscreens found in Europe and other countries, so experts at Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, advocate better use of the products we have. Sylvester Comprehensive Cancer Center /articles/sylvester-cancer-tip-sheet-june-2024/?sc=rsin /articles/sylvester-cancer-tip-sheet-june-2024/?sc=rsin Fri, 21 Jun 2024 15:05:29 EST A hematologist endorses FDA approval of a new cancer drug, research shows new use for an older drug, multiple myeloma research may secure FDA approval of a new clinical endpoint, a bilingual thoracic oncologist breaks down language barriers for cancer patients, and more are in the June tip sheet. Sylvester Comprehensive Cancer Center /articles/dr-estelamari-rodriguez-honored-as-grace-patient-educator-of-the-year/?sc=rsin /articles/dr-estelamari-rodriguez-honored-as-grace-patient-educator-of-the-year/?sc=rsin Mon, 03 Jun 2024 14:05:39 EST In recognition of her work breaking down language barriers around the world by creating Spanish-language educational content about lung cancer for patients and caregivers, Sylvester Comprehensive Cancer Center's Dr. Estelamari Rodriguez has been honored as GRACE Patient Educator of the Year. Sylvester Comprehensive Cancer Center /articles/study-access-to-targeted-lung-cancer-drug-is-cost-prohibitive-globally/?sc=rsin /articles/study-access-to-targeted-lung-cancer-drug-is-cost-prohibitive-globally/?sc=rsin Thu, 30 May 2024 14:05:35 EST A new study that examined the cost-effectiveness of durvalumab, a targeted immunotherapy for lung cancer, could help guide drug-pricing strategies to reduce financial burdens and increase the number of patients who benefit from treatment. Sylvester Comprehensive Cancer Center /articles/benefit-of-rituximab-maintenance-after-first-line-bendamustine-rituximab-in-mantle-cell-lymphoma/?sc=rsin /articles/benefit-of-rituximab-maintenance-after-first-line-bendamustine-rituximab-in-mantle-cell-lymphoma/?sc=rsin Wed, 29 May 2024 12:05:44 EST Sylvester Comprehensive Cancer Center /articles/assessing-gender-disparities-in-oncology-less-talk-more-action/?sc=rsin /articles/assessing-gender-disparities-in-oncology-less-talk-more-action/?sc=rsin Wed, 29 May 2024 12:05:37 EST Sylvester Comprehensive Cancer Center /articles/strategist-1-a-first-in-human-fih-phase-1-study-of-idrx-42-in-patients-with-metastatic-gastrointestinal-stromal-tumors-resistant-to-prior-treatment-with-tyrosine-kinase-inhibitors-tkis/?sc=rsin /articles/strategist-1-a-first-in-human-fih-phase-1-study-of-idrx-42-in-patients-with-metastatic-gastrointestinal-stromal-tumors-resistant-to-prior-treatment-with-tyrosine-kinase-inhibitors-tkis/?sc=rsin Wed, 29 May 2024 12:05:29 EST Sylvester Comprehensive Cancer Center /articles/biomarker-analyses-in-patients-with-advanced-renal-cell-carcinoma-arcc-from-the-phase-3-clear-trial/?sc=rsin /articles/biomarker-analyses-in-patients-with-advanced-renal-cell-carcinoma-arcc-from-the-phase-3-clear-trial/?sc=rsin Wed, 29 May 2024 12:05:05 EST Sylvester Comprehensive Cancer Center /articles/safety-and-efficacy-of-first-in-class-cxcr12-inhibitor-sx-682-in-combination-with-pembrolizumab-pem-in-patients-pts-with-metastatic-melanoma-mmel-with-disease-progression-on-anti-pd-1-therapy/?sc=rsin /articles/safety-and-efficacy-of-first-in-class-cxcr12-inhibitor-sx-682-in-combination-with-pembrolizumab-pem-in-patients-pts-with-metastatic-melanoma-mmel-with-disease-progression-on-anti-pd-1-therapy/?sc=rsin Wed, 29 May 2024 11:05:19 EST Sylvester Comprehensive Cancer Center /articles/post-transplant-cyclophosphamide-based-graft-versus-host-disease-prophylaxis-following-mismatched-unrelated-donor-peripheral-blood-stem-cell-pbsc-transplantation/?sc=rsin /articles/post-transplant-cyclophosphamide-based-graft-versus-host-disease-prophylaxis-following-mismatched-unrelated-donor-peripheral-blood-stem-cell-pbsc-transplantation/?sc=rsin Wed, 29 May 2024 11:05:02 EST Sylvester Comprehensive Cancer Center